关注
Enes Kemal Ergin
Enes Kemal Ergin
PhD Candidate, University of British Colombia, BC Children's Hospital Research Institute
在 bcchr.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Sensitive determination of proteolytic proteoforms in limited microscale proteome samples
SSH Weng, F Demir, EK Ergin, S Dirnberger, A Uzozie, D Tuscher, ...
Molecular & Cellular Proteomics 18 (11), 2335-2347, 2019
872019
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways
AC Uzozie, EK Ergin, N Rolf, J Tsui, A Lorentzian, SS Weng, L Nierves, ...
bioRxiv, 2019
202019
Identification of small molecule binding pocket for inhibition of Crimean? Congo hemorrhagic fever virus OTU protease
F Kocabaş, EK Ergin
Turkish Journal of Biology 40 (1), 239-249, 2016
52016
Squapp—simple quantitative analysis of proteins and ptms
EK Ergin, AC Uzozie, S Chen, Y Su, PF Lange
Bioinformatics 38 (21), 4956-4958, 2022
42022
Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia
AC Lorentzian, J Rever, EK Ergin, M Guo, NM Akella, N Rolf, ...
Nature Communications 14 (1), 7161, 2023
22023
Statistical Testing for Protein Equivalence Identifies Core Functional Modules Conserved across 360 Cancer Cell Lines and Presents a General Approach to Investigating …
EK Ergin, JJK Myung, PF Lange
Journal of Proteome Research, 2024
2024
Proteomics and personalized patient-derived xenograft models identify treatment opportunities for a progressive malignancy within a clinically actionable timeframe and change care
GD Barnabas, TA Bhat, V Goebeler, P Leclair, N Azzam, N Melong, ...
medRxiv, 2024.07. 04.24309923, 2024
2024
Persistence of targetable lesions, predicted therapy sensitivity and proteomes through disease evolution in pediatric acute lymphoblastic leukemia
AC Lorentzian, J Rever, EK Ergin, M Guo, NM Akella, N Rolf, CJ Lim, ...
medRxiv, 2022.03. 04.22271927, 2022
2022
Patient-Derived Xenograft Models Recapitulate The Proteome and Functional Capacity of Primary Pediatric Acute Lymphoblastic Leukemia but Divert in Select Pathways
A Uzozie, E Ergin, A Lorentzian, N Rolf, CJ Lim, G Reid, C Maxwell, ...
PEDIATRIC BLOOD & CANCER 68, S185-S186, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–9